Drosophila Spitz is a homolog of transforming growth factor a (TGF-a) and is an activating ligand for the EGF receptor (Egfr). It has been shown that Star is required for Spitz activity. Here we show that Star is quantitatively limiting for Spitz production during eye development. We also show that Star and Spitz proteins colocalize in Spitz sending cells and that this association is not coincident with the site of translation ± consistent with a function for Star in Spitz processing or transmission. Finally, we have de®ned minimal sequences within both Spitz and Star that mediate a direct interaction and show that this binding can occur in vivo. q
Introduction
The Drosophila homolog of the EGF receptor (Egfr) mediates signal transduction during many aspects of development, including regulation of the cell-cycle and patterning during oogenesis, zygotic and imaginal development (Schweitzer and Shilo, 1997; Freeman, 1998; Nilson and Schu Èpbach, 1999; Bier, 2000; Carpenter, 2000; Schlessinger, 2000) . In the developing eye, Egfr signaling mediates the speci®cation of the eye itself, cell growth and survival, the recruitment of cells to the developing ommatidia, and the induction of development in the optic lobes of the brain (Xu and Rubin, 1993; Sawamoto and Okano, 1996; Dickson, 1998; Dominguez et al., 1998; Huang et al., 1998; Kumar et al., 1998; Spencer et al., 1998; Chen and Chien, 1999; Moses, 2000, 2001; Yang and Baker, 2001) .
The ®rst of several positively acting Egfr ligands known in Drosophila was Spitz, which is a single EGF domain growth factor homolog in the transforming growth factor a (TGF-a)/glial growth factor (GGF) family (Aaronson, 1991; Rutledge et al., 1992; Schweitzer et al., 1995) . spitz acts in patterning the dorsal chorionic appendages, the embryonic cuticle, central nervous system and the imaginal discs (Mayer and Nu Èsslein-Volhard, 1988; Schweitzer et al., 1995; Golembo et al., 1996; O'Keefe et al., 1997; Stemerdink and Jacobs, 1997; Szuts et al., 1997; Wasserman and Freeman, 1998) . In the developing eye, Spitz is required for the assembly of the ommatidia after the speci®cation of the founding R8 photoreceptor cell (Freeman, 1994 (Freeman, , 1996 Tio et al., 1994; Tio and Moses, 1997) . At least some of these functions in the developing eye appear to be conserved in vertebrates (Reh and Cagan, 1994; Bermingham-McDonogh et al., 1996; Neumann and Nu Èsslein-Volhard, 2000) .
The Drosophila Star protein and another family of proteins called Rhomboids are required in the Spitz sending cell for the proper function of Spitz in all stages of development, including the developing eye (Bier et al., 1990; Heberlein and Rubin, 1991; Freeman et al., 1992; Heberlein et al., 1993; Kolodkin et al., 1994; Schweitzer et al., 1995; Sturtevant and Bier, 1995; Queenan et al., 1997; Schweitzer and Shilo, 1997; Stemerdink and Jacobs, 1997; Freeman, 1998; Guichard et al., 1999; Wasserman et al., 2000) . Star is an integral membrane protein that is expressed in cells that secrete Spitz and is localized to the early endoplasmic reticulum (ER) and nuclear envelope (Kolodkin et al., 1994; Pickup and Banerjee, 1999) . However, while Rhomboid is also an integral membrane protein, it has been localized to apical patches only (Sturtevant et al., 1996) . This difference in subcellular localization suggests that Star may act at an earlier point than Rhomboid in the pathway of Spitz maturation. Schweitzer and co-workers showed that Star and Rhomboid function is required for the signaling activity of ectopically expressed full-length Spitz (`membrane' or mSpitz') but not for the activity of a truncated form of Spitz that does not require cleavage to release the factor domain (`secreted' or`sSpitz', Schweitzer et al., 1995) . This suggests that Star and Rhomboid both act in the production of a functional Spitz signal in the sending cell and, furthermore, that they may function in the maturation of the Spitz factor: in protein cleavage, glycosylation, secretion or presentation. In a conceptually similar experiment, the expression of Drosophila Spitz in a Xenopus animal cap sandwich assay has been shown to require both Star and Rhomboid (Bang and Kintner, 2000) . The very fact that Star nulls are haploinsuf®cient dominant mutations with a rough eye phenotype indicates that Star is genetically dose sensitive and suggests that Star function may be quantitatively limiting on the Spitz signal during eye development (Harris et al., 1976; Mayer and Nu Èsslein-Volhard, 1988) . Finally, the published subcellular localizations of Star protein at the EM level and of Spitz by confocal microscopy suggest that Star may interact directly with Spitz at some point during its translation, maturation, secretion or presentation (Tio and Moses, 1997; Pickup and Banerjee, 1999) .
In this paper, we present data that support the direct interaction of Star with Spitz in vivo in the developing eye. We show that Spitz and Star proteins colocalize in developing retinal cells by confocal microscopy and that the quantitative expression of Star can control the quantitative expression of Spitz ± in both loss and gain-of-function Star genotypes in the developing eye. Furthermore, as previously reported (Freeman, 1996) , we con®rm that ectopic expression of mSpitz has no phenotypic consequence unless accompanied by the overexpression of Star. We show that the binding of Star to Spitz is mediated by the 48-residue domain of Spitz and by a 19-amino-acid segment of Star (which we call the`growth factor binding domain' or GFBD) and that these two short protein segments can direct the colocalization of`cargo' proteins to the same sub-cellular compartment when expressed in HeLa cells. These data will be discussed in terms of models for the function of Star protein in Spitz signaling in vivo.
Results

Spitz and Star proteins are colocalized within developing photoreceptor cells
We and others have shown that Star acts genetically upstream of spitz, that Star is required for the function of full length (m)Spitz but not a truncated secreted form (s)Spitz and that Star protein can be detected in the nuclear envelope and early ER (Schweitzer et al., 1995; Golembo et al., 1996; Pickup and Banerjee, 1999; Bang and Kintner, 2000) . Furthermore, Star has an essential role in the developing eye (Heberlein and Rubin, 1991; Heberlein et al., 1993) . We thus examined the subcellular expression patterns of both Spitz and Star proteins as well as spitz RNA in the developing eye by immunolocalization and/or RNA in situ hybridization and confocal microscopy (see Fig. 1 and Section 4).
To detect Spitz protein, we used a mouse polyclonal antiserum that was raised against a portion of Spitz that lies Nterminal to the fully processed growth factor-homologous domain (Tio and Moses, 1997) . Thus the Spitz antigen detected in the experiments described below can only include precursor forms of the Spitz protein within the cells that express it ± we are unlikely to be visualizing the mature secreted factor (`s-Spitz'). We ®nd that Spitz antigen is found throughout the cytoplasm of the developing photoreceptor cells (Fig. 1A ,D, as published in Tio and Moses, 1997) . The Spitz protein is granular rather than evenly distributed and these granules are both perinuclear (Fig.  1D ) and located in the apical microvillae (Fig. 1A) . Star protein is somewhat more evenly distributed (Fig. 1B ,E,H) but is most abundant in granules that colocalize with the Spitz granules (Fig. 1C,F ). This is consistent with an early association of Star with nascent Spitz protein in the ER (as published by Pickup and Banerjee, 1999) and the maintenance of this association all the way to the site of signal transmission (the apical microvillae). However, we cannot draw any ®rm conclusion that Spitz and Star are adjacent proteins in the ER in vivo from these data alone: while if they are naturally adjacent, they are likely to be ®xed in close proximity to each other by the action of the PLP (2% paraformaldehyde, 0.01 M NaIO 4 , 0.075 M lysine, 0.037 M NaPO 4 , pH 7.4) ®xative but the normal subcellular membranes are probably disrupted by the subsequent washing step that includes triton. To further explore this proposed direct interaction between Spitz and Star, we have undertaken biochemical experiments described below.
Moreover, we found that spitz mRNA, while showing a granular distribution, does not colocalize with the Star/Spitz protein granules (Fig. 1I ). This suggests that Star is not directly involved in spitz translation. The Star antigen appears to be more abundant than Spitz in these images. However, this experiment is far from quantitative and we are reluctant to draw any conclusion from this observation.
Star function is the limiting factor for the quantity of Spitz antigen in vivo
While it was clear from published work that Star is required for the expression of Spitz, it was not obvious that the quantity of Star is normally limiting for Spitz expression. To test this, we examined the expression of Spitz antigen in the developing eye in conditions of both loss-of-function for Star and of Star ectopic expression (Fig.  2) . In Star mutant (loss-of-function) mosaic clones Spitz antigen is greatly reduced (Fig. 2A±C ). That it is not entirely absent may be due to the accumulation of some amount of unprocessed Spitz precursor protein. We observe that Spitz protein level in the Star mutant clones was not visibly reduced in the furrow itself (arrow in Fig. 2A,C ), but only in the later columns of developing ommatidia. It may be that Star is not limiting for Spitz protein expression in the furrow itself and that the later loss is due to a reduced number of differentiating photoreceptor cells in the clone.
We expressed Star ectopically in the developing eye by inducing mosaic clones with ey:FLP to drive the eye tissue to consist entirely of recombinant cells (see Section 4). FRT-mediated recombination is operationally a one-way process: after mitosis, the two daughter cells are homozygous. Under these conditions, FLPase is expressed in the eye anlagen continuously. Thus as development proceeds, the pool of un-recombined cells is progressively depleted. By the third instar, the eyes are entirely composed of cells homozygous for one or other of the two chromosomes.
These clones were visualized using negative marking with b-galactosidase and the cells within these clones are also homozygous for a Star cDNA driven by an hsp70 gene promoter. Thus the third instar eye imaginal disc consists of patches of cells that express b-galactosidase and are wildtype for Star and patches of cells that are negative for bgalactosidase and which express elevated levels of Star ectopically. When Star protein is thus overexpressed in mosaic clones, Spitz antigen now appears anterior to the morphogenetic furrow (Fig. 2D±F ). This indicates that the quantity of Star is normally limiting for the expression of Spitz ± at least in some parts of the developing eye (i.e. anterior to the morphogenetic furrow). This must depend on the observed low levels of spitz mRNA anterior to the furrow (Tio et al., 1994; Tio and Moses, 1997) .
Others have shown that Star loss-of-function mutant cells die in the developing eye (Heberlein and Rubin, 1991; Heberlein et al., 1993) . Thus the loss of Spitz antigen in our Star loss-of-function clones (see Fig. 2A±C ) could be trivially due to the apoptotic death of these cells. To test this, we visualized apoptotic cells in Star loss-of-function clones using TUNEL (Fig. 3A) . We ®nd that there is cell death in these clones, but that it occurs far posterior to the furrow (about 10 ommatidial columns or 20 h after the passage of the furrow). Furthermore, we were able to visualize the near-normal expression of several other proteins in these clones in the region of the furrow: Atonal (Ato in Fig.  3B ) as well as Elav and Boss (data not shown). Thus we conclude that living cells are present within the Star loss-offunction clones for about 1 day after the passage of the furrow. Furthermore, these cells are suf®ciently vigorous to express at least three other proteins. Our observation that they fail to express Spitz is thus not a simple consequence of cell morbidity, but is a differential effect of loss of Star function. This is consistent with a direct role for Star in Spitz protein expression.
For further evidence that Star function is normally limiting for Spitz function in vivo, we drove ectopic and elevated levels of unprocessed full-length or`mSpitz' expression in the developing eye using an GMR:Gal4 driver (see Section 4). We ®nd that the resulting adult compound eye is indistinguishable from wild-type (Fig. 4A ). This suggests that the quantity of spitz mRNA expression is not normally limiting for spitz function in the developing eye. We similarly overexpressed Star and this results in a moderate rough eye phenotype (Fig. 4B ). This suggests that the quantity of Star function may be limiting in normal development. When we expressed both mSpitz and Star together in the same animal, we observed a strong synergy (Fig. 4C) . We observed smooth eyes with little or no red pigment and few mechanosensory bristles. This suggests a de®cit of accessory cells. When we stained the third instar eye imaginal discs from these animals, we observed that most or all nuclei in the late developing ommatidial clusters stain for Elav (Fig. 4D±F) . This is consistent with their differentiation as extra photoreceptor cells and may explain the reduced number of accessory cells. Indeed, a very similar result was observed for the function of these proteins in the developing wing (Pickup and Banerjee, 1999) . The fact that elevating levels of mSpitz has no gross effect on the developing eye until Star protein is also elevated is consistent with a normal limiting function for Star on Spitz expression. 
The EGF homologous`factor' domain of Spitz protein mediates speci®c binding to Star in vitro
The colocalization of Spitz and Star proteins is consistent with direct contact between these two proteins in vivo. To approach this, we tested a series of fragments of Spitz fused to glutathione-S-transferase (GST) for their ability to bind to full-length (66 kDa) Star protein expressed in vitro and labeled with 35 S-methionine (see Section 4). We made seven such protein fusions (SpitzA±GST through SpitzG± GST, Fig. 5 ) and ®nd that the SpitzC fragment strongly interacts with Star and that SpitzF interacts weakly (Fig.  5) . However, we found that the weak binding of SpitzF is not speci®c ± it also binds luciferase and all sub-fragments of Star tested (see below). Thus we suggest that SpitzC (residues 71±125) contains the major, high-speci®city binding domain for Star protein. An eighth Spitz fragment (SpitzH, residues 75±122) is very similar to but slightly smaller than SpitzC and behaves identically in this assay (data not shown). SpitzC and SpitzH closely contain the domain of Spitz, which is cleaved to release the six cysteine containing EGF homologous`factor' domain (residues 78± 122). Thus our data are consistent with Spitz binding to Star via the factor domain.
A 19-amino-acid fragment from Star protein mediates speci®c binding to Spitz in vitro
We also sought to de®ne the minimal domain within Star that is responsible for binding to Spitz. We repeated the binding experiments described above using GST±SpitzC and a series of seven sub-fragments of Star,
35
S labeled in vitro (called Star1 through Star7, see Fig. 6 ). Each Star fragment was tested for binding to GST alone and to GST±SpitzC. While Star1 and Star2 both bind GST±SpitzC, they also bind equally well to GST alone. We thus cannot demonstrate any speci®c SpitzC binding activity in Star1 or Star2. However, both Star4 and Star5 do bind speci®cally to SpitzC and these two fragments overlap over a short range (residues 402±421). To con®rm this location for a speci®c GFBD, we expressed a smaller fragment: Star7 (residues 390±420). As this fragment is too small to be labeled in vitro by our protocol, we fused this to yellow¯uorescent protein (YFP). We ®nd that this Star7±YFP fusion is speci®cally precipitated by GST±SpitzC (Fig. 6) . As a control, we tested YFP alone and found that it is not precipitated by either GST±SpitzC or GST alone. Our data are thus consistent with a GFBD within Star that lies between the N-terminal residue of Star5 and the C-terminal amino acid of Star7 ± a domain of only 19 residues.
The factor domain of Spitz and the GFBD of Star can interact in vivo
Our in vitro experiments (above) suggest that Spitz binds to Star via the factor domain and that Star binds to Spitz via the 19-residue GFBD we de®ned. However, in vitro studies like these may be prone to artifacts and require in vivo Confocal image of the edge of a third instar eye imaginal disc, red ± Elav (neural nuclei), green ± actin. Overexpression of mSpitz has no effect and is indistinguishable from wild-type (A). Overexpression of Star has a moderate effect (B). Overexpression of both Star and mSpitz together is synergistic (C). In the double overexpression (C), there is a de®cit of accessory cells resulting in a smooth eye and an excess of photoreceptor neurons. Close to the furrow (arrowhead in D±F), there is a near normal array of single neurons. However, as ommatidial assembly proceeds across the disc, excess numbers of neurons are recruited into each cluster (arrows in D±F). Scale bar in (A) is 100 mm (B,C to the same scale). Scale bar in (D) is 25 mm (E,F to the same scale). The N and C termini and the trans-membrane domain are indicated. Below are seven sub-fragments (1±7, see Section 4). These fragments were individually labeled and precipitated with GST±Spitz fragment C (SpitzC) and glutathione±agarose beads complexed to GST alone (GST, as a control) as shown in the gels. Protein fragment sizes indicated in kDa. Note that as Star7 is fused to YFP, it runs high on the gel (see Section 4). Note that Star fragment 2 is equally precipitated by both Spitz and GST ± and we therefore consider this binding non-speci®c. Note that fragments 4, 5 and 7 de®ne a minimal sequence that is speci®cally bound by Spitz fragment C. . The N and C termini and the signal sequence, mature factor and transmembrane domains are indicated. Below are seven sub-fragments that were fused to GST (A±G, see Section 4). These were used to precipitate 35 S-methionine labeled Star protein (66 kDa) as shown. Also shown are two controls: glutathione±agarose beads alone (BDS) and glutathione±agarose beads bound to GST alone (GST). Note that fragment`C' strongly precipitates Star (dark shading) and fragment`F' does so only weakly. However, Fragment`F' binds other targets such as luciferase (data not shown) and we therefore consider this binding non-speci®c. Fragment C' does not bind to a control target (luciferase) in this assay.
con®rmation. To approach this, we expressed two readily detectable`cargo proteins' in tissue culture (HeLa) cells and then used these to test for the ability of the Spitz factor domain and the Star GFBD to cause the`cargo' proteins to colocalize.
The`cargo' proteins were yellow and cyan¯uorescent proteins (YFP fused to another fragment to yield YFP±pyru-vate kinase (PK) and CFP). When YFP±PK is transfected into HeLa cells, it is evenly distributed between the nucleus and the cytoplasm (Fig. 7A) . We directed CFP to the nucleus by adding a nuclear localization sequence from SV40 virus large T antigen (CFP±nuclear localization signal (NLS), Kalderon et al., 1984a,b) and when transfected into HeLa cells, as expected CFP±NLS is nuclear (Fig. 7E) . When the two fusion proteins (YFP±PK and CFP±NLS) are cotransfected into HeLa cells, YFP±PK remains generally distributed and CFP is nuclear. This shows that the two fusion proteins do not normally bind signi®cantly to each other in HeLa cells.
We then fused the 48 amino-acid SpitzH fragment (containing the factor domain) to CFP±NLS to yield CFP± SpitzH±NLS and as expected, this fusion protein is still directed to the nucleus when expressed in HeLa cells (Fig.  7B,H) . We fused the GFBD containing Star7 fragment to YFP±PK to yield YFP±Star7±PK and, as expected the protein remains evenly distributed (Fig. 7D) . However, when CFP±SpitzH±NLS and YFP±Star7±PK are coexpressed in HeLa cells, both the cyan and the yellow¯uor-escent labels colocalize predominantly to the cell's nuclei (Fig. 7G±I ). This suggests that the two proteins bind together in the HeLa cells' cytoplasm and are then cotranslocated into the nucleus by virtue of the SV40 NLS on the CFP±SpitzH±NLS partner. Control experiments show that translocation of the yellow label (YFP) to the nucleus requires both SpitzH and Star7 ± either one alone will not mediate binding (Fig. 7A±F) . It is important to note that we do not suggest that either Spitz or Star are normally nuclear proteins. We used this colocalization assay only to demonstrate that the Spitz factor domain and the Star GFBD are capable of signi®cant and stable binding in a living cell.
Discussion
Genetic analysis indicated that Star (with rhomboid) may function upstream of the transmission of Spitz from sending cells (Schweitzer et al., 1995; Bang and Kintner, 2000) and Star protein has been shown to be localized to the nuclear envelope and the early ER (Pickup and Banerjee, 1999) . Taken together, these data suggested to us that Star may function in the translation, post-translational cleavage, glycosylation, secretion or presentation of Spitz. To approach this, we localized Star and Spitz proteins and spitz mRNA in a series of pair-wise double stains at the confocal level. We found that Spitz and Star proteins do colocalize, but that spitz RNA does not. Furthermore Spitz and Star proteins appear together in granular structures that are perinuclear as well as apical in the cells. This suggests that the Spitz±Star interaction persists through much or all of the secretory pathway.
We found that controlling the quantity of Star directly affects the quantity of Spitz antigen seen (in loss and gainof-function mosaic clones and by ectopic expression in the entire eye). In short, less Star results in less Spitz and more Star in more (and ectopic) Spitz. Consistent with this, we found that overexpression of mSpitz alone has no phenotypic effect, but that overexpression of Star does result in a moderate rough eye suggesting that normally spitz RNA is in excess and the quantity of the signal is limited by Star. Furthermore, overexpressing both mSpitz and Star together results in a synergistic effect ± and a grossly disordered eye, with a large excess of photoreceptors and a de®cit of accessory cells. As the main function of the Spitz/Egfr signal in the eye is to recruit cells to the developing clusters and specify them as photoreceptor neurons, this phenotype is consistent with a great increase in the quantity of this signal. Our immuno-colocalization data appear to suggest that there is more Star antigen than Spitz in the developing eye (Fig. 1) . However, it is very dif®cult to draw any conclusions as to the actual relative abundance of these proteins ± these experiments were not quantitative. Taken together, all these data suggest that the quantity of Star protein is the critical limiting factor for the Spitz/Egfr signal, at least during the normal development of the compound eye.
We have also used a series of GST-mediated in vitro binding experiments to de®ne a single region each in Spitz and Star that mediate their direct interaction (Fig.  8) . In Spitz, this 48-residue segment (SpitzH) is virtually identical to the`factor' domain ± that part of the protein that contains the six cysteine residues and other features that show homology to the small diffusible growth factors of the TGF-a family (Massague Â, 1990; Derynck, 1992) . In Star, we have de®ned a 19-amino-acid GFBD responsible for binding to Spitz. To con®rm these results, we conducted a test in vivo: we fused SpitzH to CFP as well as a dominant NLS. This CFP±SpitzH±NLS fusion when expressed in HeLa cells is directed to the nucleus by virtue of the NLS and a cyan-colored signal is detected there by confocal microscopy. We also made a fusion protein in which an evenly distributed YFP±PK protein was fused to the GFBD from Star (YFP±Star7±PK). When YFP±Star7±PK is expressed alone in HeLa cells, the yellow signal is evenly distributed, but when coexpressed with CFP±SpitzH±NLS, the yellow signal moves to the nucleus. This`cargo' experiment con®rms that the Spitz factor domain and the Star GFBD can bind in vivo. Taken together, the in vitrò GST-pull down' experiments and the in vivo HeLa cell cargo' experiments are consistent with a direct interaction in the living¯y between the Spitz factor domain and the Star GFBB. However, neither of these two experiments tested this interaction in the secretory pathway.
It is interesting to note that the Spitz`factor' domain is Nterminal to the Spitz trans-membrane domain ± and thus presumed to lie outside of the plasma membrane (or in the lumen of the organelles of the secretory pathway). The GFBD in Star lies C-terminal to its trans-membrane domain and thus would appear to lie on the wrong side of the plasma or organelle membranes to interact directly with the Spitz factor domain. However, structural features of Star have led others to suggest that Star is actually a type II integral protein, with its C-terminus outside and its N-terminus inside (Kolodkin et al., 1994) . This is therefore consistent with a direct interaction between the Spitz factor domain and the Star GFBD in vivo.
In summary, we have shown that Spitz and Star proteins associate in living cells in the developing Drosophila compound eye, that Star controls the quantity of Spitz signal and that these proteins interact via the factor domain in Spitz and the GFBD (we de®ned) in Star. Our data are consistent with a role for Star in some stage or stages of Spitz signal production subsequent to its translation. These conclusions are very similar to those reached by others for Rhomboid family proteins (Bier et al., 1990; Freeman et al., 1992; Sturtevant et al., 1993; Schweitzer et al., 1995; Sturtevant et al., 1996; Sapir et al., 1998; Guichard et al., 1999; Bang and Kintner, 2000; Wasserman et al., 2000) . While we can draw no ®rm conclusions from our data, we suggest that Star may be involved in a complex in the secretory pathway that acts in the maturation of Spitz. Star could act before Rhomboid as Star has been localized early in the pathway (Pickup and Banerjee, 1999) and Rhomboid has been localized to the apical microvillae (Sturtevant et al., 1996) or they may act together. There is no evidence to suggest that either Star or Rhomboid are themselves proteases capable of cleaving Spitz: perhaps they recruit one. Alternately Star may act as a chaperone to route the pro-Spitz protein correctly within the secretory pathway or it might be required for the correct folding of Spitz or it may recruit glycosylation enzymes. Indeed, our data suggest that Star can interact with the Spitz factor domain in vitro in conditions in which it may not be correctly folded. It is interesting to note that anterior to the furrow, in the developing eye that Star appears to be quantitatively limiting on Spitz expression. It may be that Spitz pro-protein that is not correctly routed or cleaved may be unstable.
While there are several known Rhomboid proteins, Star appears to be unique in the Drosophila genome. While homologs of Rhomboid have been detected in vertebrates (Guichard et al., 1999; Wasserman et al., 2000) , we have been unable to detect any homolog of Star outside of Drosophila, either by searching for similarities to the entire protein sequence or to the GFBD alone. We have shown that Star is essential in Drosophila for the activation of an otherwise inactive growth factor homolog (Spitz). There may be proteins with similar functions in vertebrates, which have conserved structure but which are too far diverged at the primary sequence level to be found with current computer searching algorithms.
Experimental procedures
4.1. Immunolocalization, RNA in situ hybridization and microscopy For immunolocalization, imaginal discs were prepared and stained largely as described by Tomlinson and Ready (1987) with minor modi®cations: discs were dissected in 0.1 M NaPO 4 , pH 7.4, then ®xed at room temperature for 30±45 min in`PLP'. This solution was made fresh before use. After ®xation, discs were transferred to 0.1 M NaPO 4 , pH 7.4, 0.1% Triton X-100 and washed for 1 h at room temperature. They were then transferred to 0.1 M NaPO 4 , pH 7.4, 0.1% Triton X-100, 10% normal goat serum to block for 15 min. Then discs were transferred to the primary antibody (dilution optimized for each antibody used) in 0.1 M NaPO 4 , pH 7.4, 0.1% Triton X-100, 10% normal goat serum overnight at 48C. Then discs were transferred to 0.1 M NaPO 4 , pH 7.4, 0.1% Triton X-100 and washed for 20 min, twice. Then discs were transferred to 0.1 M NaPO 4 , pH 7.4, 0.1% Triton X-100, 10% normal goat serum and washed and blocked for 20 min. Next discs were transferred to secondary antibody (dilution optimized for each antibody used) in 0.1 M NaPO 4 , pH 7.4, 0.1% Triton X-100, 10% normal goat serum and incubated at room temperature for 3 h. For colocalization, primary antibodies were: mouse anti-Spitz (Tio and Moses, 1997) ; rat anti-Star (Pickup and Banerjee, 1999) . Secondary antibodies were: HRP± donkey anti-rat (ML, Jackson Lab); Cy5-rat anti-mouse (ML, Jackson Lab). HRP-donkey anti-rat was ampli®ed using a Tyramide kit (NEN/Life Science Products). In mosaic clone experiments, b-galactosidase (LacZ) protein was visualized using either Rabbit anti-b-galactosidase (Cortex Biochem) or mouse anti-b-galactosidase (Promega) primary antibodies and FITC±goat anti-rabbit (Jackson Labs) or Cy5±goat anti-mouse (Jackson Labs) secondaries, as appropriate. Atonal protein was visualized with rabbit anti-ATO (Jarman et al., 1994) primary antibody and Cy5±rat anti-mouse (ML, Jackson Labs) secondary antibody. Elav protein was visualized with rat anti-ELAV (Developmental Studies, Hybridoma Bank) primary and FITC±goat anti-rat (Jackson Labs). Boss protein was visualized with mouse anti-Boss (Kra Èmer et al., 1991) primary and Cy5±rat anti-mouse (ML, Jackson Labs) secondary antibody. For spitz RNA in situ hybridization, digoxigenin-labeled DNA probes were prepared by polymerase chain reaction (PCR) from a spitz cDNA clone BA3 (Tio et al., 1994) . Hybridization and visualization were as published (Kumar and Moses, 2001 ). Apoptotic cells were detected by TUNEL stain (Intergen Company) using the manufacturer's protocols. Filamentous actin was visualized with rhodamine-conjugated phalloidin (Molecular Probes). Fluorescent images were obtained using a Zeiss LSM510 confocal microscope. Scanning electron microscopy (SEM) was as previously described (Moses et al., 1989) .
Genetics and mosaic clone analysis
For colocalization of Spitz and Star proteins in the developing eye, imaginal discs from w; hs-S 8 /In(2LR)O third instar larvae raised continuously at 258C were prepared as previously described (Tomlinson and Ready, 1987) . hs-S 8 was as previously described (Kolodkin et al., 1994) . Star loss-of-function clones were obtained from third instar larvae of the genotype: ey:FLP/1; S 126 FRT40A/ p(conD)25A FRT 40A. p(conD)25A drives general expression of b-galactosidase in the eye disc (Tio and Moses, 1997) . Star ectopic expression clones were obtained from third instar larvae of the genotype: ey:FLP/1; hs-S 8 FRT43D/FRT43D P(arm:LacZ). Star and mSpitz were misexpressed using UAS-S 4-3 (Golembo et al., 1996) and UAS-mSpi (Freeman, 1996) driven by GMR:Gal4 (Pignoni and Zipursky, 1997) .
